CHM Price sensitive 2 Oct 2025, 9:42 AM

Additional complete responses in CHM CORE-NK Phase 1b trial

Chimeric Therapeutics Ltd

Sign in to open PDF

No summary is available for this announcement — sign in to read the PDF in full.

Sign in for more about this company, including guidance changes and other insights.
Sign in